Orchard Therapeutics plc ORTX
Set alert
16.70 0.00 0.00%
At close · Jan 23
16.64 Day range 16.72
52-week range unavailable
- Open
- 16.65
- Prev close
- 16.70
- Mkt cap
- 380.11M
- Vol
- 372.35K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 16.64
- High
- 16.72
- Forward P/E
- -3.35
- Beta
- 0.55
- Short ratio
- 0.28
- Inst. own
- 103.60%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 4, 2024
- 50-d avg
- 16.44
- 200-d avg
- 10.11
- 1y target
- 16.00
Analyst view
Consensus: hold
Hold
Price target (mean) 16.00
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy1
- Buy3
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 3
- 2 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.31 | -1.31 – -1.31 | -0.60 | -118.3% | 8.69M | +24.4% | 1 |
| Next quarter | -1.49 | -1.49 – -1.49 | -1.20 | -24.2% | 12.00M | +99.7% | 1 |
| Current year | -2.89 | -2.89 – -2.89 | -11.50 | +74.9% | 25.29M | +11.6% | 1 |
| Next year | -4.98 | -4.98 – -4.98 | -2.89 | -72.3% | 56.66M | +124.0% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 4, 2023 | Stifel | Downgrade | Buy | Hold |
| Aug 8, 2023 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 26, 2023 | Cantor Fitzgerald | Reiterated | Overweight | Overweight |
| Jun 12, 2023 | Oppenheimer | Maintained | Outperform | Outperform |
| Mar 27, 2023 | Cantor Fitzgerald | Maintained | — | Overweight |